Katrijn Grupping

Immunogenicity and Safety of an Adjuvanted Herpes Zoster Subunit Vaccine Coadministered With Seasonal Influenza Vaccine in Adults Aged 50 Years or Older

Tino F. Schwarz, Naresh Aggarwal, Beate Moeckesch et al. · The Journal of Infectious Diseases · 2017 · 80 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine

Katrijn Grupping, Laura Cámpora, Martine Douha et al. · The Journal of Infectious Diseases · 2017 · 72 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Immunogenicity and safety of an adjuvanted herpes zoster subunit candidate vaccine in adults ≥ 50 years of age with a prior history of herpes zoster: A phase III, non-randomized, open-label clinical trial

Olivier Godeaux, Martina Kovac, Daniel Shu et al. · Human Vaccines & Immunotherapeutics · 2017 · 53 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

The Impact of Reactogenicity After the First Dose of Recombinant Zoster Vaccine on the Physical Functioning and Quality of Life of Older Adults: An Open-Label, Phase III Trial

Kenneth E. Schmader, Myron J. Levin, Katrijn Grupping et al. · The Journals of Gerontology Series A · 2018 · 34 citations · Full text

Veterinary Medicine, Geriatric Medicine, Pharmacotherapy +17

MiniCD4 protein resistance mutations affect binding to the HIV-1 gp120 CD4 binding site and decrease entry efficiency

Katrijn Grupping, Philippe Selhorst, Johan Míchiels et al. · Retrovirology · 2012 · 18 citations · Full text

Life Sciences, Biology, Molecular Biology +17